Anzeige
Mehr »
Login
Samstag, 21.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
21.11.EAACI launches first World Anaphylaxis Awareness Day
21.11.Pfizer appoints Chris Boshoff as chief scientific officer and president of R&D
21.11.Measuring outcomes in medical affairs - the key components to be considered
20.11.UCB's Bimzelx granted FDA approval to treat hidradenitis suppurativa in adults
20.11.Is the new Health and Social Care Select Committee a battleground or consensus opportunity?
20.11.Bringing more effective storytelling to medical publications
19.11.Biogen/Eisai's Alzheimer's drug lecanemab receives CHMP recommendation
19.11.The potential of generative AI and its practical application in the world of promotional medical communications
19.11.Impending ESG regulations present communications opportunity for pharma
18.11.Merck gains rights to LaNova's PD-1/VEGF bispecific antibody in deal worth over $3.2bn
18.11.European Medicines Group appoints Rippon Ubhi as chair
18.11.Creative strategy in medical communications
15.11.GSK and Vesalius partner on new Parkinson's treatments in deal worth $650m
15.11.ICR researchers identify potential treatment approach for acute myeloid leukaemia
15.11.Cutting through the maze of obstacles to liberate patient pathways
14.11.Novartis and Schrödinger to advance drug candidates in deal worth over $2.4bn
14.11.Merck KGaA/Abbisko share positive phase 3 results for pimicotinib in rare tumour type
14.11.Is Gen AI ready for life sciences?
13.11.Roche and Flare Therapeutics enter oncology partnership worth over $1.8bn
13.11.AstraZeneca/Merck's Koselugo shows promise in adults with neurofibromatosis type 1
13.11.J&J's nipocalimab granted FDA breakthrough designation for Sjögren's disease
12.11.Novavax announces FDA clinical hold lift on phase 3 COVID-19/flu vaccine study
12.11.J&J submits EU and US applications for subcutaneous Darzalex in smouldering multiple myeloma
12.11.Ogilvy appoints Mario Muredda as global chief executive officer of Ogilvy Health
11.11.FDA approves Autolus' Aucatzyl to treat acute lymphoblastic leukaemia